0.35  -0.062 (-15.01%)		06-12 16:00
Open: 0.389 High: 0.408 Volume: 3,499,874		Pre. Close: 0.4118 Low: 0.34 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	0.92	1-year :	1.34
Resists	First :	0.79	Second :	1.15
Pivot price	0.36
Supports	First :	0.2	Second :	0.16
MAs	MA(5) :	0.47	MA(20) :	0.33
	MA(100) :	0.34	MA(250) :	0.97
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	17.1	D(3) :	23.2
RSI	RSI(14): 50.2
52-week	High :	3.79	Low :	0.14

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SMTK ] has closed above bottom band by 48.0%. Bollinger Bands are 85.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.41 - 0.41	0.41 - 0.41
Low:	0.34 - 0.34	0.34 - 0.34
Close:	0.35 - 0.35	0.35 - 0.35

SmartKem, Inc. focuses on developing innovative materials and processes essential for organic thin-film transistor (OTFT) backplanes, which are crucial components in the production of flexible electronic devices. Their advanced transistor technology finds application in a diverse range of products. This includes bendable smartphone screens, curved displays for vehicles, e-paper, wearable gadgets, and specialized sensors like fingerprint and printed biosensors. The company was established in 2009 and is headquartered in Manchester, United Kingdom.

Fri, 12 Jun 2026
SmartKem, Inc. (SMTK) UK subsidiary to enter creditors voluntary liquidation - Stock Titan

Mon, 08 Jun 2026
SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus - TechStock²

Mon, 08 Jun 2026
SRx Health Solutions and EMJ Crypto Announce Merger Agreement - Intellectia AI

Mon, 08 Jun 2026
SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK) - GlobeNewswire

Mon, 08 Jun 2026
SRx Health buys 4.99% of advanced materials firm Smartkem - Stock Titan

Wed, 20 May 2026
SmartKem, Inc. 1Q 2026: Revenue $20K, Net income ($19.37M), EPS ($1.34) — 10-Q Summary - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Technology
Industry: Semiconductors
Shares Out	0 (M)
Shares Float	21 (M)
Held by Insiders	2.053e+007 (%)
Held by Institutions	23.2 (%)
Shares Short	104 (K)
Shares Short P.Month	0 (K)

EPS	-1.211e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-12 %
Return on Assets (ttm)	635 %
Return on Equity (ttm)	-100 %
Qtrly Rev. Growth	694000 %
Gross Profit (p.s.)	-5.4
Sales Per Share	-250.46
EBITDA (p.s.)	173859
Qtrly Earnings Growth	-2.4 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.01
Price to Cash Flow	-1.48

Dividend	0
Forward Dividend	463030
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.